Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001209191-23-053251

President and CFO sold 8,000 shares at an average $45.91 ($367,300)

  • President and CFO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

GUGGENHIME ANDREW · President and CFO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-10-18 Exercise or conversion : show line 1 in the form 10b5-1 +8,000 $5.35 $42,800 87,474 D
2023-10-18 Sale : show line 2 in the form 10b5-1 −7,497 $45.89 $344,000 79,977 D
2023-10-18 Sale : show line 3 in the form 10b5-1 −503 $46.32 $23,300 79,474 D
Open-market sales · 8,000 sh · avg $45.91 · $367,300

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-18 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −8,000 422,827 D
Loading xslF345X05/doc4.xml…